228 related articles for article (PubMed ID: 32745996)
41. Neuromyelitis Optica Spectrum Disorder With Hyponatremia as an Initial Presentation: A Case Report.
Yang S; Tian J; Huang H; Yan Z
Clin Ther; 2021 Dec; 43(12):2168-2172. PubMed ID: 34772517
[TBL] [Abstract][Full Text] [Related]
42. Optic neuritis after ocular trauma in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Akaishi T; Himori N; Takeshita T; Fujihara K; Misu T; Takahashi T; Fujimori J; Ishii T; Aoki M; Nakazawa T; Nakashima I
Brain Behav; 2021 May; 11(5):e02083. PubMed ID: 33591639
[TBL] [Abstract][Full Text] [Related]
43. Intractable hiccups, nausea, and vomiting, an unnerving cause of vision loss.
Kumar SM; Venkatraman V; Kowsalya A; Narayanamoorthy J; Jayasudha M
Oman J Ophthalmol; 2022; 15(3):366-369. PubMed ID: 36760931
[TBL] [Abstract][Full Text] [Related]
44. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
[TBL] [Abstract][Full Text] [Related]
45. A Missed Case of Area Postrema Syndrome Presenting with Neuromyelitis Optica Spectrum Disorder.
Khan F; Sharma N; Ud Din M; Aziz M
Am J Case Rep; 2022 Jan; 23():e934649. PubMed ID: 35046381
[TBL] [Abstract][Full Text] [Related]
46. Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder.
Smith AD; Moog TM; Burgess KW; McCreary M; Okuda DT
Mult Scler Relat Disord; 2023 Feb; 70():104498. PubMed ID: 36610360
[TBL] [Abstract][Full Text] [Related]
47. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
48. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
49. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
50. Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis.
Kim SH; Hyun JW; Joung A; Lee SH; Kim HJ
PLoS One; 2016; 11(12):e0167783. PubMed ID: 27936193
[TBL] [Abstract][Full Text] [Related]
51. Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy.
Munger KC; Samkoff LM
Mult Scler Relat Disord; 2020 Jan; 37():101442. PubMed ID: 32173005
[TBL] [Abstract][Full Text] [Related]
52. Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Hamada Y; Takahashi K; Kanbayashi T; Hatanaka Y; Kobayashi S; Sonoo M
Intern Med; 2021 May; 60(10):1611-1614. PubMed ID: 33361678
[TBL] [Abstract][Full Text] [Related]
53. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
54. Area postrema syndrome: A short history of a pearl in demyelinating diseases.
Camara-Lemarroy CR; Burton JM
Mult Scler; 2019 Mar; 25(3):325-329. PubMed ID: 30463481
[TBL] [Abstract][Full Text] [Related]
55. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
56. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
57. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
58. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
59. Neuromyelitis optica spectrum disorders.
Huda S; Whittam D; Bhojak M; Chamberlain J; Noonan C; Jacob A
Clin Med (Lond); 2019 Mar; 19(2):169-176. PubMed ID: 30872305
[TBL] [Abstract][Full Text] [Related]
60. Eleven episodes of recurrent optic neuritis of the same eye for 22 years eventually diagnosed as neuromyelitis optica spectrum disorder.
Yew YC; Hor JY; Lim TT; Kanesalingam R; Ching YM; Arip M; Easaw PE; Eow GB
Mult Scler Relat Disord; 2016 Nov; 10():22-25. PubMed ID: 27919493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
